Trial Profile
A phase III study to compare the efficacy of APC-500 and Advair
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 05 Mar 2015
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 05 Mar 2015 New trial record